Henoch-Schönlein purpura in childhood: Review of 214 patients

Yıl 2012, , 91 - 95, 01.03.2012

Aydın Ece İlyas Yolbaş Hasan Balık Halil Kocamaz Servet Yel Ünal Uluca İlhan Tan

https://doi.org/10.5799/ahinjs.01.2012.01.0118

Öz

Objectives: Due to involvement of various systems and clinical variety of in Henoch-Schönlein purpura (HSP), in this study, it was aimed to investigate clinical and laboratory features of children with HSP. Materials and methods: Hospital records of 214 children with HSP followed up between 2000 and 2007 at Dicle University Hospital Pediatrics Clinics were retrospectively evaluated. Diagnosis was made based on the HSP criteria of American College of Rheumatology. Age, gender, clinical findings, laboratory variables, applied treatments, and outcome were recorded. Results: Totally 214 HSP patients (121 male, 93 female) with the mean age of 9.0 ± 3.2 years (range, 2-16) were included. There was a history of upper respiratory tract infection in 136 children (63.6%). There was abdominal pain in 62.1% of patients, vomiting in 22.1%, and occult blood in stool or melena in 25.4%. Three patients underwent operation due to intusception. Joint involvement was seen in 117 (54.7%) and angioedema in 73 (34.3%) of patients. Renal involvement as hematuria was seen in 63 (29.4%) children, proteinuria in 57 (26.6%), leukocyturia (9.8%), and nephritic/nephritic proteinuria in five patients. Increased IgA and C3 levels were found in 35 (16.0%) and 41 (19.3%), respectively; and decreased C3 in 23 (10.7%). Benzathine penicillin and penicillin V were used in 114 (53.5%) of children, non-steroidal anti-inflammatory drugs in 128 (59.8%) and parenteral/oral corticosteroids in 86 (40.2%). Immonusuppressives were given to 5 patients with nephrotic proteinuria following renal biopsy. Conclusions: Gastrointestinal and renal involvement in children with HSP, rarely lead to major complications.

Anahtar Kelimeler

Henoch-Schönlein purpura, child, clinical findings, laboratory results

Çocuklarda Henoch-Schönlein purpurası: 214 olgunun değerlendirilmesi

Öz

Amaç: Henoch-Schönlein purpurası\'nın (HSP) çeşitli sistemleri tutması ve klinik seyrinin farklılık göstermesi nedeniyle, bu çalışmada HSP\'li çocukların klinik ve laboratuar özelliklerinin incelenmesi amaçlandı. Gereç ve yöntem: Dicle Üniversitesi Tıp Fakültesi Çocuk Kliniğinde 2000-2007 yılları arasında izlenen HSP\'li 214 çocuk hastaya ait hasta kayıtları geriye dönüşlü olarak incelendi. Hastalık tanısı American Collage of Rheumatology\' nin HSP kriterlerine dayanılarak kondu. Hastaların yaş, cinsiyet, klinik bulgular, laboratuar değişkenler, uygulanan tedavileri ve sonuçları kaydedildi. Bulgular: Toplam 214 HSP\'li çocuk hastanın (121 erkek, 93 kız) yaş ortalaması 9.0 ± 3.2 yıl (2-16 yaş arası) idi. Hastaların 136\'sında (%63.6) bir üst solunum yolu enfeksiyonu geçirme öyküsü mevcuttu. Hastaların %62.1\'inde karın ağrısı, %22.1\'inde kusma, %25.4\'ünde dışkıda gizli kan pozitifliği veya melena saptandı, üç hasta intusepsiyon nedeniyle opere edildi. Eklem tutulumu 117 (%54.7) hastada, anjiyo ödem 73 (%34.3) hastada görüldü. Renal tutulum bulgusu olarak 63 hastada (%29.4) hematüri, 57 hastada (%26.6) proteinüri, 21 hastada (%9.8) lökositüri gözlenirken, 5 hastada nefrotik/nefritik sendrom görüldü. IgA yüksekliği 35 (%16) olguda C3 yüksekliği 41 hastada (%19.3), C3 düşüklüğü 23 hastada (%10.7) rastlandı. Tedavi olarak 114 hastaya (%53.3) benzatin penisilin+ penisilin V, 128 hastaya (%59.8) non-steroidal antiinflamatuar, 86 hastaya (%40.2) oral/parenteral steroid verildi. Nefrotik proteinürisi olan 5 hastaya renal biyopsi sonrası immunsupresif verildi. Sonuç: Henoch-Schönlein purpurasında özellikle gastrointestinal sistem ve renal tutulum nadiren önemli komplikasyonlara yol açmaktadır.

Anahtar Kelimeler

Henoch-Schönlein purpurası, çocuk, klinik bulgular, laboratuvar sonuçları

Kaynakça

• Miller ML, Pachman LM. Vasculitis syndromes: He- noch-Schönlein purpura. In: Behrman RE, Kliegman RB, Jensen HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: W.B. Saunders; 2000:729.
• Jay V. The legacy of Dr William Heberden. J Insur Med 2006;38(1):75-7.
• Peru H, Soylemezoglu O, Bakkaloglu SA, et al. He- noch Schonlein purpura in chilhood: clinical analysis of 254 cases over a 3-year period. Clin Rheumatol 2008;27(9):1087-92.
• Lahita RG. Influence of age on Henoch Schonlein pur- pura. Lancet 1997;350(9085):1116-7.
• Trapani S, Micheli A, Grisolia F. Henoch Schonlein pur- pura in childhood: Epidemiological and clinical analy- sis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35(3):143-53.
• Cassidy JT, Petty RE. Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric Rheumatology. 5 th ed. W.B. Saunders Co. Philadel- phia. 2005, p.496-501.
• Nielsen HE. Epidemiology of Schönlein Henoch pur- pura. Acta Pediatr Scand 1988;77(1):125-31.
• Ozcakar O, Fitoz S, Yalçınkaya F. Henoch Schonlein purpura. Klinik Gelişim Dergisi 2006; 19(1):52-5.
• Kawasaki Y, Suzuki J, Sakai N, et al. Clinical and path- ological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003; 60(2):153-60.
• Nuhoğlu Ç, Gedikoğlu H, Sonmez EO, Ozkozacı T, Ceran O. Henoch Schönlein Purpurası olan çocuk ol- guların demografik özellikleri ve laboratuar bulguları- nın retrospektif analizi. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi 2009;49 (2):125-9.
• Inal A, Yılmaz M, Kendirli SG, Altıntaş DU, Karakoç GB, Doğruel D. Henoch-Schönlein purpurası tanısı alan çocukların klinik özellikleri. Erciyes Tıp Dergisi 2009;31(2):153-61.
• Cakır M. Henoch-Schonlein purpura in North-Eastern Turkey. Ann Trop Paediatr 2006;26(1):59-65.
• Ersen A, Aydınoz S, Karademir F et al. Çocukluk dö- nemi Henoch-Schönlein purpurası: 42 Olgunun ret- rospektif analizi. Dirim 2009;84(2):35-41.
• Garcia-Porrua C, Calvino MC, Llorca J, Couselo JM, Gonzalez Gay MA. Henoch-Schonlein purpura in chil- dren and adults: clinical differences in a defined popu- lation. Semin Arthritis Rheum 2002;32(1):149-56.
• Sano H, Izumida M, Shimizu H, Ogawa Y. Risk fac- tors on renal involvement and significant protein- uria in Henoch Schonlein purpura. Eur J Pediatr 2002;161(2):196-201.
• Abdel-Al YK, Hejazi Z, Majeed HA. Henoch Schonlein purpura in Arab children. Analysis of 52 cases. Trop Georg Med 1990;42(1):52-7.
• Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in childhood with Henoch- Schönlein purpura. Pediatrics 1987;79(6):1018-21.
• Bagga A, Kabra SK, Srivastava RN, Bhuyan UN. Henoch- Schönlein syndrome in Northern Indian chil- dren. Indian Pediatr 1991;28(10):1153-7.
• Gow KW, Murphy JJ, Blair GK, et al. Multiple entero- entero fistulae: an unusual complication of Henoch- Schönlein purpura. J Pediatr Surg 1996;31(7):809-11.
• Kobayashi O, Wada H, Okawa K, Takeyama I. Schön- lein-Henoch’s syndrome in children. Contrib Nephrol 1975;4(1):48-71.
• Koskimies O, Mir S, Rapola J, Viska J. Henoch- Schönlein nephritis: long term prognosis of unselect- ed patients. Arch Dis Child 1981;56(3):482-4.
• Andreoli SP. Chronic glomerulonephritis, Henoch- Schönlein purpura nephritis and IgA nephropathy. Pe- diatr Clin North Am 1995;42(6):1487-503.
• Kawasaki Y, Suziki J, Nozawa R, Suziki S, Suziki H. Efficacy of metilprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pedi- atrics 2003;111(4 Pt 1):785-9.